Viewing Study NCT04602533


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-01-01 @ 5:38 AM
Study NCT ID: NCT04602533
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-17
First Post: 2020-10-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)
Sponsor: Michael Hopp
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module